Klaria Pharma Holding AB (publ.) (KLAR)
Free
No email, no account, no signup.
Pulling latest news for Klaria Pharma Holding AB (publ.)…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
Nasdaq First North Growth Market
Type
Biotech
Sector
Drug delivery and biotechnology
Market Cap
$21M
We're already tracking Klaria Pharma Holding AB (publ.) — here are the latest events we've registered
Recent News
- On April 23, 2026, Klaria issued a notice for its Annual General Meeting to be held on May 26, 2026. The company previously announced the postponement of its 2025 annual report to May 5, 2026, following an auditor change intended to prevent potential conflicts of interest. In March 2026, an extraordinary general meeting was held to approve merger plans for subsidiaries.
Want to know how this news affects Klaria Pharma Holding AB (publ.)? Order the analysis.
Order analysis – $4.99
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Klaria Pharma Holding AB (publ.) will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.